Recent News for ADPT - Adaptive Biotechnologies Corporation

Date Title
Aug 16 Andreas Halvorsen's Top 5 Buys of the 2nd Quarter
Aug 14 Adaptive Biotechnologies stock down 8.5% in premarket trade
Aug 14 Adaptive Biotechnologies Corp (ADPT) CEO Chad Robins on Q2 2019 Results - Earnings Call Transcript
Aug 13 CDK, GO and REAL among notable after hour movers
Aug 13 Adaptive Biotech loss narrower than expected on first post IPO report
Aug 13 Adaptive Biotechnologies EPS of -$1.23
Aug 13 Adaptive Biotechnologies Corporation Reports Second Quarter 2019 Financial Results
Aug 12 Ron Baron Comments on Adaptive Biotechnologies Corp
Aug 12 Notable earnings after Tuesday’s close
Aug 9 New Listings Stink Up Earnings Season After Reports Disappoint
Aug 7 Adaptive Biotechnologies signs lease for new Seattle headquarters
Aug 7 Adaptive Biotechnologies Executes Lease for New 100,000 Square Foot Corporate Headquarters, Tripling its Footprint in Seattle’s Growing Biotech Hub
Aug 6 The Daily Biotech Pulse: Sanofi's Dupixent Found Effective For Pediatric Itchy Skin, Novavax Gets Nod For Late-Stage Study, Allakos Offering
Aug 1 Adaptive Biotechnologies to Report Second Quarter Financial Results on August 13, 2019
Jul 31 Adaptive Biotechnologies Receives New York State CLEP Approval for clonoSEQ to Detect and Monitor Minimal Residual Disease (MRD) in Patients with Certain Blood Cancers
Jul 24 3 Stocks the World's Best Investors Are Buying Right Now
Jul 23 Sell-siders bullish on Karuna Therapeutics in premarket action
Jul 22 Sell-siders bullish on BridgeBio in premarket analyst action
Jul 20 The Week Ahead In Biotech: Pharma Earnings Pick Up Pace
Jul 18 Next-Generation Xbox Unveiled as China Production Cuts Loom
Jul 12 Sound Pharmaceuticals targets IPO in 2020
Jul 1 Why Freeport-McMoRan, Coty, and Adaptive Biotechnologies Slumped Today
Jul 1 Adaptive Biotechnologies Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Jul 1 Microcaps top midday movers
Jul 1 Aclaris Therapeutics and Precipio among healthcare gainers; Evofem Biosciences leads the losers
Back to the Main ADPT Page...